Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. Current Pharmaceutical Design
We issued our statement on the guideline and our CEO, who is also the Chair of the B12-Alliance, was instrumental in the text and publication of the statement of CluB-12
The absence of human trials means safety is uncharacterised
[3] Those with Leber's disease (hereditary optic neuropathy) should avoid cyanocobalamin formulations
(Heck, were excited about it, too.) Just one problem As of this writing, there are no randomized controlled trials of the effects of BPC 157 in humans
This is why you might notice that two people with seemingly identical lifestyles, including exercise and diet, can have wildly different outcomes